[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:hiv-infection":3},{"name":4,"total":5,"recruiting":6,"trials":7},"HIV Infection",80,58,[8,16,22,28,34,41,47,53,59,65,71,77,84,90,96,102,108,115,121,127,133,140,146,152,158,164,169,175,180,187,193,199,204,210,216,222,228,233,239,245,251,256,262,268,274,280,286,292,297,303],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07392372","A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV",[12],"Phase 1","RECRUITING","2026-08-26T02:17:52.450442Z","2026-07-05T05:32:16.682213Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07249840","Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis",[12],"2026-08-26T02:17:04.346841Z","2026-07-05T05:32:16.671391Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT07223398","Shared Decision Making to Treat Or Prevent (STOP) HIV in Criminal Legal Involved Populations (R33)",[],"2026-08-26T02:16:29.226604Z","2026-07-05T03:45:20.460072Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT07619339","A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer",[12],"2026-08-26T02:15:18.897219Z","2026-06-04T01:30:07.903453Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":39,"content_modified":40},"NCT05719441","A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission",[38],"Phase 2","2026-08-26T02:19:19.975067Z","2026-05-05T02:47:14.270472Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT07433673","Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)",[38],"2026-08-26T02:19:08.084946Z","2026-05-05T02:43:29.707381Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT05665738","Two-fraction HDR Monotherapy for Localized Prostate Cancer",[],"2026-08-26T02:15:58.452248Z","2026-05-05T02:43:29.533094Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT06223568","Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer",[38],"2026-08-03T03:13:22.003666Z","2026-05-05T02:43:29.471790Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":63,"content_modified":64},"NCT05655949","Y-90 With Durvalumab\u002FGem\u002FCis in Intrahepatic Cholangio",[38],"2026-08-26T02:15:36.077529Z","2026-05-05T02:43:29.327321Z",{"nct_id":66,"title":67,"phases":68,"status":13,"updated_at":69,"content_modified":70},"NCT04131413","HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia",[12],"2026-08-26T02:18:57.189473Z","2026-05-05T02:43:29.166339Z",{"nct_id":72,"title":73,"phases":74,"status":13,"updated_at":75,"content_modified":76},"NCT07425054","HPV ctDNA Response-Adapted Chemoradiation +\u002F- Retifanlimab Treatment in Advanced-Stage Anal Cancer",[38],"2026-08-26T02:16:13.426928Z","2026-05-05T02:43:28.644725Z",{"nct_id":78,"title":79,"phases":80,"status":13,"updated_at":82,"content_modified":83},"NCT07040319","Study of the Pharmacokinetics and Safety of Glecaprevir\u002FPibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV",[81],"Phase 1\u002FPhase 2","2026-08-26T02:16:18.872924Z","2026-05-05T02:43:28.558929Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT05967182","A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma",[38],"2026-08-26T02:18:24.494016Z","2026-05-05T02:43:28.207276Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT04305691","Trial of Ixazomib for Kaposi Sarcoma",[38],"2026-08-26T02:19:21.761002Z","2026-05-05T02:43:28.178229Z",{"nct_id":97,"title":98,"phases":99,"status":13,"updated_at":100,"content_modified":101},"NCT07528352","External Beam Radiotherapy Followed by Bispecific Antibody Therapy for Relapsed\u002FRefractory DLBCL",[12],"2026-08-26T02:17:01.714035Z","2026-05-05T02:43:27.930526Z",{"nct_id":103,"title":104,"phases":105,"status":13,"updated_at":106,"content_modified":107},"NCT07126158","Stereotactic Body Radiotherapy Plus FAK and RAF\u002FMEK Inhibition in Advanced Pancreatic Adenocarcinoma",[38],"2026-08-26T02:16:48.735701Z","2026-05-05T02:43:27.292720Z",{"nct_id":109,"title":110,"phases":111,"status":13,"updated_at":113,"content_modified":114},"NCT03180268","Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery",[112],"Phase 3","2026-08-26T02:17:18.747857Z","2026-05-05T02:43:27.092603Z",{"nct_id":116,"title":117,"phases":118,"status":13,"updated_at":119,"content_modified":120},"NCT04375800","Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to \u003C12 Years and \u003C45 kg (MK-1439-066)",[38],"2026-08-26T02:17:45.190188Z","2026-05-05T02:43:26.957094Z",{"nct_id":122,"title":123,"phases":124,"status":13,"updated_at":125,"content_modified":126},"NCT04499053","Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer",[38],"2026-08-26T02:18:06.247899Z","2026-05-05T02:43:26.753466Z",{"nct_id":128,"title":129,"phases":130,"status":13,"updated_at":131,"content_modified":132},"NCT04941274","Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma",[81],"2026-08-26T02:16:54.044282Z","2026-05-05T02:43:26.742813Z",{"nct_id":134,"title":135,"phases":136,"status":13,"updated_at":138,"content_modified":139},"NCT03474029","Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI",[137],"Phase 2\u002FPhase 3","2026-08-26T02:18:15.214990Z","2026-05-05T02:43:26.742542Z",{"nct_id":141,"title":142,"phases":143,"status":13,"updated_at":144,"content_modified":145},"NCT06845046","A Study to Improve Skeletal Muscle in Veterans With HIV",[],"2026-08-26T02:18:47.742071Z","2026-05-05T02:43:26.679164Z",{"nct_id":147,"title":148,"phases":149,"status":13,"updated_at":150,"content_modified":151},"NCT06854653","A Phase 2 Study of PTX 100 in Patients With Relapsed\u002FRefractory CTCL",[38],"2026-08-26T02:17:03.534765Z","2026-05-05T02:35:31.681316Z",{"nct_id":153,"title":154,"phases":155,"status":13,"updated_at":156,"content_modified":157},"NCT06572618","Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell Lymphoma",[38],"2026-08-26T02:17:35.666428Z","2026-05-05T02:35:31.599903Z",{"nct_id":159,"title":160,"phases":161,"status":13,"updated_at":162,"content_modified":163},"NCT07143968","A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV",[38],"2026-08-26T02:17:57.117858Z","2026-04-29T02:57:57.163934Z",{"nct_id":165,"title":166,"phases":167,"status":13,"updated_at":100,"content_modified":168},"NCT06213311","A Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma",[38],"2026-04-29T02:57:57.157278Z",{"nct_id":170,"title":171,"phases":172,"status":13,"updated_at":173,"content_modified":174},"NCT06554717","Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV",[38],"2026-08-26T02:16:46.951087Z","2026-07-05T05:32:16.760081Z",{"nct_id":176,"title":177,"phases":178,"status":13,"updated_at":119,"content_modified":179},"NCT05849038","Inflammation and Depression in People With HIV",[38],"2026-07-05T05:32:16.738310Z",{"nct_id":181,"title":182,"phases":183,"status":13,"updated_at":185,"content_modified":186},"NCT06829238","Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use",[184],"Phase 4","2026-08-26T02:15:27.567165Z","2026-05-05T02:43:28.728322Z",{"nct_id":188,"title":189,"phases":190,"status":13,"updated_at":191,"content_modified":192},"NCT05907759","Daratumumab for Relapsed\u002FRefractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease",[38],"2026-08-26T02:18:43.501109Z","2026-05-05T02:43:26.949844Z",{"nct_id":194,"title":195,"phases":196,"status":13,"updated_at":197,"content_modified":198},"NCT05389423","Pomalidomide and Dose-Adjusted EPOCH +\u002F- Rituximab for HIV-Associated Lymphomas",[12],"2026-08-26T02:19:23.493898Z","2026-05-05T02:35:31.746900Z",{"nct_id":200,"title":201,"phases":202,"status":13,"updated_at":156,"content_modified":203},"NCT05470491","Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...",[81],"2026-05-05T02:43:29.587324Z",{"nct_id":205,"title":206,"phases":207,"status":13,"updated_at":208,"content_modified":209},"NCT05077527","Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma",[12],"2026-08-26T02:16:01.910993Z","2026-05-05T02:43:29.044473Z",{"nct_id":211,"title":212,"phases":213,"status":13,"updated_at":214,"content_modified":215},"NCT03314974","Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders",[38],"2026-08-26T02:16:14.341106Z","2026-05-05T02:43:28.206546Z",{"nct_id":217,"title":218,"phases":219,"status":13,"updated_at":220,"content_modified":221},"NCT07097363","Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma",[38],"2026-08-26T02:19:30.857183Z","2026-05-05T02:43:27.261789Z",{"nct_id":223,"title":224,"phases":225,"status":13,"updated_at":226,"content_modified":227},"NCT06526819","SMP-3124LP in Adults With Advanced Solid Tumors",[81],"2026-08-26T02:16:23.080181Z","2026-05-05T02:43:27.129846Z",{"nct_id":229,"title":230,"phases":231,"status":13,"updated_at":75,"content_modified":232},"NCT03125642","Auto Stem Cell Transplant for Lymphoma Patients",[38],"2026-05-05T02:43:26.753431Z",{"nct_id":234,"title":235,"phases":236,"status":13,"updated_at":237,"content_modified":238},"NCT05580458","Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population",[81],"2026-08-26T02:17:23.750999Z","2026-05-05T02:43:28.484929Z",{"nct_id":240,"title":241,"phases":242,"status":13,"updated_at":243,"content_modified":244},"NCT05897099","Comprehensive HIV and Harm Prevention Via Telehealth",[],"2026-08-26T02:19:12.219640Z","2026-05-05T02:43:27.039006Z",{"nct_id":246,"title":247,"phases":248,"status":13,"updated_at":249,"content_modified":250},"NCT06843902","Improving Coronary Vascular Health in Women",[38],"2026-08-26T02:17:59.904383Z","2026-05-05T02:43:28.019851Z",{"nct_id":252,"title":253,"phases":254,"status":13,"updated_at":94,"content_modified":255},"NCT06624839","Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV",[38],"2026-04-29T02:57:57.072987Z",{"nct_id":257,"title":258,"phases":259,"status":13,"updated_at":260,"content_modified":261},"NCT02147405","PET Imaging and Lymph Node Assessment of IRIS in People With AIDS",[],"2026-08-26T02:17:47.813245Z","2026-06-18T14:29:42.728870Z",{"nct_id":263,"title":264,"phases":265,"status":13,"updated_at":266,"content_modified":267},"NCT05985642","Observational PIC Destination Cohort",[],"2026-08-26T02:17:14.343713Z","2026-05-13T02:55:06.399361Z",{"nct_id":269,"title":270,"phases":271,"status":13,"updated_at":272,"content_modified":273},"NCT05159466","Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive Donors",[],"2026-08-26T02:19:24.527214Z","2026-05-13T02:55:06.293955Z",{"nct_id":275,"title":276,"phases":277,"status":13,"updated_at":278,"content_modified":279},"NCT05026138","Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)",[],"2026-08-26T02:18:02.701182Z","2026-05-13T02:55:06.279881Z",{"nct_id":281,"title":282,"phases":283,"status":13,"updated_at":284,"content_modified":285},"NCT04142047","Skeletal Muscle Energetics and Fatiguability in Older Individuals",[],"2026-08-26T02:18:44.395098Z","2026-05-13T02:55:06.242155Z",{"nct_id":287,"title":288,"phases":289,"status":13,"updated_at":290,"content_modified":291},"NCT00039689","Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants",[],"2026-08-26T02:16:20.336282Z","2026-05-13T02:55:06.030303Z",{"nct_id":293,"title":294,"phases":295,"status":13,"updated_at":197,"content_modified":296},"NCT07087145","Feasibility of HPV Testing With Mail-delivered Sample Collection Kits",[],"2026-05-13T02:55:06.651306Z",{"nct_id":298,"title":299,"phases":300,"status":13,"updated_at":301,"content_modified":302},"NCT06055868","People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity",[],"2026-08-26T02:17:09.131534Z","2026-05-13T02:55:06.405251Z",{"nct_id":304,"title":305,"phases":306,"status":13,"updated_at":307,"content_modified":308},"NCT01206920","The DC Cohort Longitudinal HIV Status Neutral Study",[],"2026-08-26T02:19:20.945539Z","2026-05-13T02:55:06.070631Z"]